GGrantIndex
← Leaderboards

Ling He

Johns Hopkins University

$4,855,170
Attributed
$6,981,993
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,981,993 · 5

By mechanism

R01$6,076,147 · 3
R00$725,846 · 1
K99$180,000 · 1

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusHyperglycemiaKnockout MiceAffectLiverHepatocyteHepaticNon-Insulin-Dependent Diabetes MellitusMediatingPathway InteractionsLipid BiosynthesisGene ExpressionInsulin ResistanceIn VivoGlucose ProductionObese MiceSiteHigh Fat DietDoseMetabolic DiseasesFatty Acid Glycerol EstersInsulin SignalingAcetylationSmall Hairpin Rna

Grant awards (18)

Glycerol Regulation of Gluconeogenesis and Fatty Acid Metabolism$463,943
R01 · FY2025 · DK
Glycerol Regulation of Gluconeogenesis and Fatty Acid Metabolism$516,168
R01 · FY2024 · DK
Glycerol Regulation of Gluconeogenesis and Fatty Acid Metabolism$559,143
R01 · FY2023 · DK
Coactivator P300 promotes hepatic steatosis in obesity$523,897
R01 · FY2023 · DK · contact PI
Coactivator P300 promotes hepatic steatosis in obesity$532,127
R01 · FY2022 · DK · contact PI
Coactivator P300 promotes hepatic steatosis in obesity$539,185
R01 · FY2021 · DK · contact PI
Coactivator P300 promotes hepatic steatosis in obesity$547,859
R01 · FY2020 · DK · contact PI
Activation of the cAMP-PKA pathway antagonizes metformin action$364,500
R01 · FY2020 · DK · contact PI
Coactivator P300 promotes hepatic steatosis in obesity$571,325
R01 · FY2019 · DK · contact PI
Activation of the cAMP-PKA pathway antagonizes metformin action$364,500
R01 · FY2019 · DK · contact PI
Activation of the cAMP-PKA pathway antagonizes metformin action$364,500
R01 · FY2018 · DK · contact PI
Activation of the cAMP-PKA pathway antagonizes metformin action$364,500
R01 · FY2017 · DK · contact PI
Activation of the cAMP-PKA pathway antagonizes metformin action$364,500
R01 · FY2016 · DK · contact PI
The Distinct Role of CBP and p300 in Regulating Hepatic Glucose Production$232,058
R00 · FY2013 · DK · contact PI
The Distinct Role of CBP and p300 in Regulating Hepatic Glucose Production$244,788
R00 · FY2012 · DK · contact PI
The Distinct Role of CBP and p300 in Regulating Hepatic Glucose Production$249,000
R00 · FY2011 · DK · contact PI
The Distinct Role of CBP and p300 in Regulating Hepatic Glucose Production$90,000
K99 · FY2011 · DK · contact PI
The Distinct Role of CBP and p300 in Regulating Hepatic Glucose Production$90,000
K99 · FY2010 · DK · contact PI